US animal drug manufacturer Zoetis has lost its challenge a ruling that chucked out three of its patents for a single-dose vaccine to protect pigs from enzootic pneumonia.
Years of hard fought litigation by axed Qantas ground crew and generic drug maker Sandoz ended in victory this week, thanks to legal eagles from Maurice Blackburn and Ashurst and their counsel. The week opened with a bang with a decision from Federal Court Justice Michael Lee in three landmark test cases by the Transport…
Infant formula company Care A2 has found new lawyers as trial begins in a trade mark dispute with rival a2 Milk.
Care A2 is set to miss the trial in its trade mark fight with rival A2 Milk after the baby formula company was ditched by its lawyers at Ashurst days ago.
Novartis unit Sandoz is appealing a tribunal decision in favour of pharmaceutical company Lundbeck over a licence to sell a generic version of leading antidepressant Lexapro.
Aristocrat has asked the High Court to rule once and for all on whether its popular Lightning Link game is patentable, after a differently comprised court was evenly split on the question.
Pharmaceuticals giant Lundbeck has succeeded in overturning IP Australia’s decision granting Novartis unit Sandoz a licence to sell a generic version of top-selling antidepressant Lexapro.
A judge has allowed Aristocrat to appeal a judge’s rejection of its application to patent its Lightning Link poker machine, citing novel questions raised by an equally split High Court decision about the patentability of its invention.
A judge has granted a limited stay of an injunction against US sports merchandise Fanatics after AFL merchandise maker FanFirm won its case alleging the US company knew about its ‘Fanatics’ trade marks.
AFL merchandise maker FanFirm has won a trade mark case against US sports merchandise giant Fanatics, with a judge finding it knew about the Australian company’s ‘Fanatics’ trade marks when it chose its corporate name.